CONMED Corp (CNMD)
About CONMED Corp
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.4B
- Net income
- $47.1M
- Total assets
- $2.3B
- Market cap
- $1.1B
- Gross margin
- 54.6%
- Operating margin
- 7.5%
- Net margin
- 3.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.4B
- Cost of revenue
- $624.2M
- Gross profit
- $750.5M
- Operating expenses
- $647.9M
- Operating income
- $102.6M
- Income tax
- $24.1M
- Net income
- $47.1M
- EPS (basic)
- $1.52
- EPS (diluted)
- $1.51
Balance sheet
- Total assets
- $2.3B
- Current assets
- $672.9M
- Total liabilities
- $1.3B
- Current liabilities
- $315.0M
- Shareholders’ equity
- $1.0B
Cash flow
- Operating cash flow
- $170.7M
- Investing cash flow
- -$21.0M
- Financing cash flow
- -$135.8M
- Net cash flow
- $16.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.1B
- P/E ratio
- 28.3
- EPS (diluted)
- $1.51
- Dividend yield
- 1.87%
- Shares outstanding
- 24.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 23, 1987
CONMED Corp (CNMD) Stock Price
- Profitable — net income of $47.1M in FY2025.
- Revenue grew 36% from FY2021 to FY2025.
- Gross margin of 54.6%, net margin 3.4%.
- Trading 24% below its 52-week high.
- Pays a dividend yielding about 1.87% annually.
- Valued at a price-to-earnings (P/E) ratio of 28.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review CONMED Corp.
Write a review
News about CONMED Corp
News & sentiment via Polygon.io
CONMED Corp: frequently asked questions
Is CONMED Corp an American company?
CONMED Corp is a US-based company headquartered in Largo, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is CONMED Corp headquartered?
CONMED Corp is headquartered in Largo, Florida, United States.
Is CONMED Corp publicly traded?
Yes — CONMED Corp is a publicly traded company. Its stock trades under the ticker symbol CNMD on the NYSE.
What does CONMED Corp do?
CONMED Corp is an American Medical Devices company in the Health & Beauty sector.
